Obagi, Valeant Raise Price As Bidding War Breaks Out
socalTECH
APRIL 3, 2013
Long Beach-based aesthetic medicine developer Obagi Medical Products , and would-be acquirer Valeant Pharmaceuticals , which is based in Aliso Viejo, said this morning that Valeant has raised its offer to acquire Obagi to $24.00 per share in cash. The move comes a day after Obagi said it received an unsolicited bid of $22.00
Let's personalize your content